Himuka AM Pharma
Miyazaki
About Himuka AM Pharma
Himuka AM Pharma is a pharmaceutical company focusing on the development of Adrenomedullin derivatives. Himuka AM Pharma creates drug candidates based on the bioactive peptide adrenomedullin (AM), which was discovered at the University of Miyazaki (formerly Miyazaki Medical College). Their drug candidates will make significant contributions to the resolution of unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.5M
- Last round: Corporate Round (Jun 2018)
- Website: himuka-am.com
- Phone: +81 0985-69-3287
Industries & Categories
Health Care, Medical Device, mHealth
Social Profiles
Canonical: https://fsome.com/organization/himuka-am-pharma-47288 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.